Update link here

Educate

A 10-year review of mBC

The Global Status of Advanced/Metastatic Breast Cancer 2005-2015 Decade Report analyzed the metastatic breast cancer (mBC) landscape over the past decade to highlight gaps in patient care, access to resources and support, and treatment outcomes for women around the world. This report was developed by Pfizer Oncology, working collaboratively with the European School of Oncology (ESO) under the framework of the International Consensus Conference for Advanced Breast Cancer (ABC). 

A steering committee of global multidisciplinary mBC advisors—composed of physicians, leaders of patient support organizations, and patients—contributed to the development of this report. 

Decade Report cover
Select a document to view or download:

THE FULL REPORT

Decade Report cover

THE REPORT SUMMARY

Decade Report cover

SECTION 1: PATIENT CARE PERSPECTIVES  

decade_report_section_1

SECTION 2: SOCIETY AND COMMUNITY IMPACT 

decade_report_section_2

SECTION 3: SCIENTIFIC LANDSCAPE

decade_report_section_3

SURVEY: GENERAL PUBLIC’S UNDERSTANDING & PERCEPTIONS OF mBC

GENERAL PUBLIC’S UNDERSTANDING and PERCEPTIONS OF mBC

SURVEY: MANAGEMENT, SUPPORT & PERCEPTION OF mBC PATIENT NEEDS 

SURVEY MANAGEMENT, SUPPORT and PERCEPTION OF mBC PATIENT NEEDS

SURVEY: ROLE & FUNCTION OF PATIENT SUPPORT ORGANIZATIONS

SURVEY ROLE and FUNCTION OF PATIENT SUPPORT ORGANIZATIONS

Update link here